{
    "code": "52026157",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026157",
    "time": "2019-05-17 03:05:51",
    "許可證字號": "衛部藥輸字第026157號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/10\/04",
    "發證日期": "102\/10\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202615709",
    "中文品名": "吸補力吸入膠囊50微克",
    "英文品名": "Seebri Breezhaler 50 microgram, inhalation powder hard capsules",
    "適應症": "慢性阻塞性肺疾之維持治療。",
    "劑型": "430吸入用膠囊劑",
    "包裝": "30粒膠囊盒裝內含1個吸入器",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "Glycopyrroniumbromide"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "FES0106000  NOVARTIS FARMACEUTICA S.A.",
        "製造廠廠址": "RONDA SANTA MARIA, 158, 08210 BARBERA DEL VALLES BARCELONA, SPAIN",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FCH0088200  NOVARTIS PHARMA AG",
            "製造廠廠址": "LICHTSTRASSE 35 CH-4056 BASLE SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002410",
            "成分名稱": "Glycopyrronium bromide",
            "含量描述": "(equivalent to Glycopyrronium 0.050mg)",
            "含量": "0.0630000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "吸補力吸入膠囊 50微克-仿單-106-12-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026157&Seq=006&Type=9"
        },
        {
            "title": "Seebri-104-09-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026157&Seq=004&Type=8"
        }
    ]
}